Researchers developed AI models using EHR and patient-reported outcomes to identify cancer survivors at high risk for emergency visits and worsening symptoms.
Key Details
- 1Study by Sylvester Comprehensive Cancer Center (University of Miami) published in JCO Clinical Cancer Informatics (May 2026).
- 2AI models analyzed data from over 25,000 cancer survivors followed for three years.
- 3Combined EHR and PRO data to predict unplanned healthcare use (ED visits, hospitalizations) and elevated symptom burden.
- 4Recent clinical activity helped predict acute events, while long-term PRO trends improved symptom prediction.
- 5Adding PROs nearly doubled symptom forecasting accuracy compared to using clinical data alone.
- 6Top 10% of risk-flagged patients accounted for half of downstream healthcare events and symptom episodes.
Why It Matters
Integrating AI-based risk stratification into survivorship care could enable earlier, more targeted interventions for cancer survivors. This demonstrates the evolving potential of medical AI to support proactive patient management across radiology-adjacent fields.
Source
EurekAlert
Related News
•EurekAlert
AI-Driven Molecular Profiling Enhances Thrombosis Risk Prediction
Researchers create an AI model integrating genetic, clinical, and transcriptomic data to identify individuals at risk for thrombosis.
•EurekAlert
USC Receives $3M Gift for Alzheimer's Research Involving Imaging and AI
A $3 million donation to USC will accelerate Alzheimer's research, including imaging modality development and AI-based molecular analysis.
•EurekAlert
AI Pathology Analysis Predicts Immunotherapy Response in Rare Tumors
AI-based analysis of tumor pathology slides can predict immunotherapy outcomes in rare cancers, according to a recent MD Anderson study.